Douglas Kitch

3.0k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Douglas Kitch is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Douglas Kitch has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Emergency Medicine, 24 papers in Infectious Diseases and 14 papers in Virology. Recurrent topics in Douglas Kitch's work include HIV-related health complications and treatments (29 papers), HIV/AIDS drug development and treatment (19 papers) and HIV Research and Treatment (14 papers). Douglas Kitch is often cited by papers focused on HIV-related health complications and treatments (29 papers), HIV/AIDS drug development and treatment (19 papers) and HIV Research and Treatment (14 papers). Douglas Kitch collaborates with scholars based in United States, Japan and Israel. Douglas Kitch's co-authors include Grace A. McComsey, Paul E. Sax, Eric S. Daar, Belinda Ha, Pablo Tebas, Kathleen Melbourne, Camlin Tierney, Nasreen C. Jahed, Laurie Myers and Todd T. Brown and has published in prestigious journals such as PLoS ONE, Hepatology and Neurology.

In The Last Decade

Douglas Kitch

37 papers receiving 1.8k citations

Hit Papers

Bone Mineral Density and Fractures in Antiretroviral-Naiv... 2011 2026 2016 2021 2011 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Kitch United States 21 1.2k 994 678 288 267 38 1.8k
Corrilynn O. Hileman United States 18 702 0.6× 402 0.4× 366 0.5× 163 0.6× 99 0.4× 48 1.0k
Julian Falutz Canada 27 1.3k 1.1× 857 0.9× 679 1.0× 536 1.9× 63 0.2× 79 2.2k
Michelle A. Kendall United States 19 623 0.5× 521 0.5× 301 0.4× 464 1.6× 110 0.4× 37 1.4k
María Larrousse Spain 24 511 0.4× 878 0.9× 464 0.7× 630 2.2× 48 0.2× 50 1.7k
Allison Ross Eckard United States 18 618 0.5× 401 0.4× 256 0.4× 150 0.5× 55 0.2× 47 956
Vanessa C. Williams United States 18 415 0.3× 458 0.5× 336 0.5× 97 0.3× 36 0.1× 33 1.4k
Jussi Sutinen Finland 25 1.1k 0.9× 754 0.8× 606 0.9× 503 1.7× 70 0.3× 48 1.8k
Carlee Moser United States 16 497 0.4× 402 0.4× 319 0.5× 138 0.5× 52 0.2× 50 1.0k
M Pang China 15 777 0.6× 477 0.5× 381 0.6× 272 0.9× 12 0.0× 27 1.9k
Caryn G. Morse United States 17 208 0.2× 231 0.2× 122 0.2× 327 1.1× 109 0.4× 36 805

Countries citing papers authored by Douglas Kitch

Since Specialization
Citations

This map shows the geographic impact of Douglas Kitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Kitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Kitch more than expected).

Fields of papers citing papers by Douglas Kitch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Kitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Kitch. The network helps show where Douglas Kitch may publish in the future.

Co-authorship network of co-authors of Douglas Kitch

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Kitch. A scholar is included among the top collaborators of Douglas Kitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Kitch. Douglas Kitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalli, Jesmond, Douglas Kitch, Meagan P. O’Brien, et al.. (2023). Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention. EBioMedicine. 89. 104468–104468. 6 indexed citations
2.
Presti, Rachel M., Brett Williams, Alan Landay, et al.. (2021). A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infectious Diseases. 8(12). ofab550–ofab550. 12 indexed citations
3.
Kitch, Douglas, et al.. (2019). Assessment of Carbon Monoxide Exposure among Women Cooking With Biomass Fuels and Their Children Living in Sudan. 2019(1). 1–7. 1 indexed citations
4.
Gupta, Samir K., Douglas Kitch, Todd T. Brown, et al.. (2017). Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s. PMC. 1 indexed citations
5.
Grant, Philip, Douglas Kitch, Grace A. McComsey, et al.. (2016). Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS. 30(18). 2805–2813. 65 indexed citations
6.
Kitch, Douglas, et al.. (2015). Markers of renal disease and function are associated with systemic inflammation in HIV infection. HIV Medicine. 16(10). 591–598. 30 indexed citations
7.
Longenecker, Chris T., Douglas Kitch, Paul E. Sax, et al.. (2015). Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(2). 168–177. 10 indexed citations
8.
Wyatt, Christina, Douglas Kitch, Samir K. Gupta, et al.. (2014). Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. PMC. 1 indexed citations
9.
Gupta, Samir K., Douglas Kitch, Camlin Tierney, et al.. (2014). Cystatin C-Based Renal Function Changes After Antiretroviral Initiation: A Substudy of a Randomized Trial. Open Forum Infectious Diseases. 1(1). ofu003–ofu003. 8 indexed citations
10.
Wyatt, Christina, Douglas Kitch, Samir K. Gupta, et al.. (2014). Changes in Proteinuria and Albuminuria With Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 36–44. 14 indexed citations
11.
Overton, Edgar T., Douglas Kitch, Constance A. Benson, et al.. (2013). Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death. Clinical Infectious Diseases. 56(10). 1471–1479. 50 indexed citations
12.
Grant, P. M., Douglas Kitch, Grace A. McComsey, et al.. (2013). Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation. Clinical Infectious Diseases. 57(10). 1483–1488. 86 indexed citations
13.
McComsey, Grace A., Douglas Kitch, Paul E. Sax, et al.. (2013). Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(2). 167–174. 52 indexed citations
14.
Erlandson, Kristine M., Douglas Kitch, Camlin Tierney, et al.. (2013). Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS. 27(13). 2069–2079. 37 indexed citations
15.
Powis, Kathleen M., Douglas Kitch, Anthony Ogwu, et al.. (2011). Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy. The Journal of Infectious Diseases. 204(4). 506–514. 159 indexed citations
16.
McComsey, Grace A., Douglas Kitch, Eric S. Daar, et al.. (2011). Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202. The Journal of Infectious Diseases. 203(12). 1791–1801. 381 indexed citations breakdown →
17.
McComsey, Grace A., Douglas Kitch, Paul E. Sax, et al.. (2011). Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s. Clinical Infectious Diseases. 53(2). 185–196. 94 indexed citations
18.
Tungsiripat, Marisa, Douglas Kitch, Marshall J. Glesby, et al.. (2010). A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206. AIDS. 24(11). 1781–1784. 101 indexed citations
19.
Evans, Scott, David M. Simpson, Douglas Kitch, et al.. (2007). A Randomized Trial Evaluating Prosaptide™ for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain. PLoS ONE. 2(7). e551–e551. 35 indexed citations
20.
Kitch, Douglas, et al.. (2006). Predictors of Antiretroviral-Related Hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999). JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(3). 320–323. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026